Constant BCR-ABL transcript level ≥0.1% (IS) in patients...

Experimental Hematology 2010 Vol. 38; Iss. 1

Constant BCR-ABL transcript level ≥0.1% (IS) in patients with CML responding to imatinib with complete cytogenetic remission may indicate mutation analysis

Kateřina Machová Poláková, Václava Polívková, Jana Rulcová, Hana Klamová, Tomáš Jurček, Dana Dvořáková, Daniela Žáčková, Zdeněk Pospíšil, Jiří Mayer, Jana Moravcová
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
38
Year:
2010
Language:
english
Pages:
7
DOI:
10.1016/j.exphem.2009.10.003
File:
PDF, 282 KB
english, 2010
Conversion to is in progress
Conversion to is failed